Pneumococcal Conjugate Vaccine Safety in Elderly Adults

BACKGROUND: The 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) were both recommended to adults aged ≥65 years. The study examines adults ≥65 years for risk of adverse events (AEs) requiring medical attention following vaccination with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Tseng, Hung Fu, Sy, Lina S, Qian, Lei, Liu, In-Lu A, Mercado, Cheryl, Lewin, Bruno, Tartof, Sara Y, Nelson, Jennifer, Jackson, Lisa A, Daley, Matthew F, Weintraub, Eric, Klein, Nicola P, Belongia, Edward, Liles, Elizabeth G, Jacobsen, Steven J
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Major Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6016414/
https://ncbi.nlm.nih.gov/pubmed/29977960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados